249 related articles for article (PubMed ID: 22801997)
1. Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.
Chen ZW; Weinreb I; Kamel-Reid S; Perez-Ordoñez B
Head Neck Pathol; 2012 Dec; 6(4):422-9. PubMed ID: 22801997
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
Wong KS; Krane JF; Jo VY
Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
[TBL] [Abstract][Full Text] [Related]
3. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
4. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?
Thomas J; Primeaux T
Ann Diagn Pathol; 2012 Apr; 16(2):91-9. PubMed ID: 22197546
[TBL] [Abstract][Full Text] [Related]
5. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma.
Xu B; Ghossein R; Lane J; Lin O; Katabi N
Hum Pathol; 2016 Aug; 54():193-200. PubMed ID: 27105759
[TBL] [Abstract][Full Text] [Related]
6. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
Ribeiro EA; Maleki Z
J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
[TBL] [Abstract][Full Text] [Related]
7. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
[TBL] [Abstract][Full Text] [Related]
8. [The testing strategy for detection of biologically relevant infection of human papillomavirus in head and neck tumors for routine pathological analysis].
Kašpírková J; Ondič O; Cerná K; Skálová A
Cesk Patol; 2013 Jan; 49(1):29-34. PubMed ID: 23432073
[TBL] [Abstract][Full Text] [Related]
9. p16 immunohistochemistry can be used to detect human papillomavirus in oral cavity squamous cell carcinoma.
Duncan LD; Winkler M; Carlson ER; Heidel RE; Kang E; Webb D
J Oral Maxillofac Surg; 2013 Aug; 71(8):1367-75. PubMed ID: 23642549
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status.
Abi-Raad R; Prasad ML; Gilani S; Garritano J; Barlow D; Cai G; Adeniran AJ
Cancer Cytopathol; 2021 May; 129(5):394-404. PubMed ID: 33369885
[TBL] [Abstract][Full Text] [Related]
11. The Fidelity of p16 Staining as a Surrogate Marker of Human Papillomavirus Status in Fine-Needle Aspirates and Core Biopsies of Neck Node Metastases: Implications for HPV Testing Protocols.
Holmes BJ; Maleki Z; Westra WH
Acta Cytol; 2015; 59(1):97-103. PubMed ID: 25765380
[TBL] [Abstract][Full Text] [Related]
12. Correlation of p16 immunostaining in cell-blocks with corresponding tissue specimens for squamous cell carcinomas of the oropharynx.
Song SJ; Jalaly JB
Cytopathology; 2021 Jan; 32(1):100-107. PubMed ID: 32886831
[TBL] [Abstract][Full Text] [Related]
13. p16 immunohistochemistry for primary tumor detection in HPV-positive squamous cell carcinoma of unknown primary.
Shan A; Rooper LM; Ryan JF; Eisele DW; Fakhry C
Am J Otolaryngol; 2021; 42(5):103015. PubMed ID: 33857776
[TBL] [Abstract][Full Text] [Related]
14. Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes.
Barasch S; Mohindra P; Hennrick K; Hartig GK; Harari PM; Yang DT
Am J Surg Pathol; 2016 Sep; 40(9):1261-9. PubMed ID: 27186851
[TBL] [Abstract][Full Text] [Related]
15. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
Dreyer JH; Hauck F; Barros MHM; Niedobitek G
Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Diagnostic Utility of a High-Risk Human Papillomavirus PCR Test on Formalin-Fixed, Paraffin-Embedded Head and Neck Tumor Tissues.
Huho AN; Yadak N; Bocklage TJ; Yang S
J Mol Diagn; 2018 Mar; 20(2):232-239. PubMed ID: 29277636
[TBL] [Abstract][Full Text] [Related]
17. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
[TBL] [Abstract][Full Text] [Related]
18. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
19. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
[TBL] [Abstract][Full Text] [Related]
20. Cytologic evaluation of p16 staining in head and neck squamous cell carcinoma in CytoLyt versus formalin-fixed material.
Buonocore DJ; Fowle E; Lin O; Xu B; Katabi N; Cohen JM
Cancer Cytopathol; 2019 Dec; 127(12):750-756. PubMed ID: 31600033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
